In-Person Access Only | 3.00 CE/CME Credits

This accredited oncology education program delivers a comprehensive and timely update on the most practice-changing data of 2025 across a broad spectrum of tumor types. Designed for busy oncology professionals, the agenda features succinct, expert-led presentations, an engaging keynote session, and valuable networking opportunities. Attendees will gain practical insights to immediately apply in clinical practice, ensuring they remain at the forefront of emerging standards of care.

This accredited meeting will be hosted in person only, with on-demand access available exclusively to registered attendees.

Conference Agenda
Friday, December 5, 2025

10:00 AM
Registration Coffee and Exhibits

10:30 AM
Welcome Remarks & Overview

10:35 AM
Lung Cancer: New Standards in 1L Advanced NSCLC
Nagashree Seetharamu, MD | Northwell Health Cancer Institute

10:50 AM
Head & Neck Cancers: Emerging Evidence
Alexander Barbaro, MD | Northwell Health Cancer Institute

11:05AM
Lunch Break and Exhibits 

11:20 AM
Non CME Session - Novartis - Addressing the Needs of Patients Across the HR+HER2- Landscape: The Role of Kisqali in eBC and mBC
Kara Trlica, FNP-BC, AOCNP | Novartis

11:50 AM
GI Cancers: Upper GI (Gastric, Esophageal & Pancreas) 
Dan King, MD | Northwell Health Cancer Institute

12:05 PM
GI Cancers: CRC Adjuvant, Neoadjuvant & Metastatic
Fernand Bteich, MD | Northwell Health Cancer Institute

12:20 PM
Keynote Session: Practice-Changing Advances in Oncology
Andrea Cercek, MD | Memorial Sloan Kettering Cancer Center

12:50 PM
Skin & Melanoma Oncology: Novel Therapeutics
Bhuvanesh Singh, MD | Northwell Health Cancer Institute 

1:05 PM
Updates in Prostate and Bladder Cancer Treatment
Shaheer Khan, MD | Northwell Health Cancer Institute

1:20 PM
Break and Exhibits 

1:35 PM
GYN Cancers: Ovarian, Uterine and Cervical Cancer Advances
Veena John, MD | Northwell Cancer Institute

1:50 PM
Breast Cancer: Early-Stage Treatment Strategies
Francisco Esteva, MD | Northwell Cancer Institute

2:05 PM
Breast Cancer: mBC and Antibody-Drug Conjugates
Kit Cheng, MD | Northwell Cancer Institute

2:20 PM
Panel Discussion & Q&A 
Richard Carvajal, MD | Northwell Health Cancer Institute (Moderator)
Kai Tsao, MD | Northwell Health Cancer Institute
Matthew Weiss, MD | Northwell Health Cancer Institute
Alain Borczuk, MD | Northwell Health Cancer Institute

2:40 PM
Closing Remarks & Takeaways

2:45 PM
Closing Reception & Networking

3:30 PM
ADJOURN

Agenda Subject To Change. All times are EST.

• Learning Objectives

  • Review and analyze recent advances in the multi-modality treatment of solid tumors and hematologic malignancies, including practice-changing data from 2025 clinical trials.

  • Identify specific clinical trials available to patients with advanced or refractory cancers across various tumor types and stages of disease.

  • Describe actionable molecular or genetic alterations that guide therapy selection and support the use of targeted or immunologic agents in personalized cancer care.

  • Discuss the integration of novel therapies into current treatment algorithms, including sequencing and combination strategies across disease states.

  • Evaluate emerging strategies to reduce disparities in cancer care, including efforts to improve clinical trial access and representation among underserved populations.

• Accreditation Information | 3.00 CE/CME

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 3.00 ANCC contact hours.

  Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 3.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 3.00 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program